Literature and evidence database
Find the source, the model and the boundary.
Search source records connected to the product-family knowledge base. Filter by category, product, publication year, research type, study model and editorial evidence tier.
Product evidence maps
A focused source set for each product.
Search and filter
Evidence records
Narrow the records by product, year or study model. Open each source to check its results and limitations.
Bachem: peptide notation and terminal modifications
Bachem: peptide notation and terminal modifications. Accessed 2026-10-03.
Bachem: Quality Control of Amino Acids and Peptides
Bachem: Quality Control of Amino Acids and Peptides. Accessed 2026-10-05.
Thermo Fisher: Peptide Analyzing Tool and its limitations
Checked 2026-10-05; source scope is identified in the article.
Thermo Fisher: Peptide Design guide
Checked 2026-10-05; source scope is identified in the article.
Agilent: Five Tips for Chromatographic Integration
Agilent: Five Tips for Chromatographic Integration. Accessed 2026-10-05.
Original MOTS-c exercise, aging and muscle-homeostasis study
Checked 2026-10-05; source scope is identified in the article.
Rice et al., eLife (2026): MOTS-c is a mitochondrial-encoded interferon-linked host defense peptide
Original publication; reported findings apply to its study material and model. Checked 2026-10-04.
Thermo Fisher: handling and storage instructions for standard peptides
Thermo Fisher: handling and storage instructions for standard peptides. Accessed 2026-10-03.
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis
Lee C, et al. Cell Metabolism. 2015. PMID 25738453.
Certain Bulk Drug Substances That May Present Significant Safety Risks
U.S. FDA. Current compounding safety-information page.
Care and handling of peptides
Care and handling of peptides
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction.
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction.
Peptide Isolation – Method Development Considerations
Peptide Isolation – Method Development Considerations
Humanin peptide suppresses apoptosis by interfering with Bax activation
Humanin peptide suppresses apoptosis by interfering with Bax activation
Humanin induces conformational changes in the apoptosis regulator BAX and sequesters it into fibers, preventing mitochondrial outer-membrane permeabilization
Humanin induces conformational changes in the apoptosis regulator BAX and sequesters it into fibers, preventing mitochondrial outer-membrane permeabilization
Analyzing Kinetic Binding Data
Analyzing Kinetic Binding Data
Solubility Guidelines for Peptides
Solubility Guidelines for Peptides
ICH Q2(R2): Validation of Analytical Procedures
Defines validation characteristics and distinguishes quantitative analytical purposes.
Research news reference — pubmed.ncbi.nlm.nih.gov — news-15
Research news reference — pubmed.ncbi.nlm.nih.gov — news-14
Research news reference — pubmed.ncbi.nlm.nih.gov — news-13
Primary publication — PubMed 39077591
Primary publication — PubMed 37834399
Primary publication — PubMed 31109005
ICH Q2(R2) Validation of Analytical Procedures
ICH Q2(R2) Validation of Analytical Procedures
The International System of Units (SI), 9th edition
The International System of Units (SI), 9th edition
ICH Q1A(R2) Stability Testing of New Drug Substances and Products
ICH Q1A(R2) Stability Testing of New Drug Substances and Products
Teaching reference — database.ich.org — ICH_Q2(R2)_Guideline_2023_1130_ErrorCorrection_2025.pdf
Editorial methodology
How records are classified
Records are deduplicated by source URL and linked to every relevant product family. Study type and model are inferred from the citation and editorial evidence label, then reviewed during content QA.
Read the full editorial, AI-assistance and correction policy →
Labels and databases supporting regulatory status, formulation or chemical identity.
Controlled trials, systematic reviews and other clinical records with population-specific interpretation.
Animal, cell, analytical and mechanistic records that cannot establish human outcomes.
Narrative reviews, registries and sponsor reports kept visibly distinct from peer-reviewed outcomes.
Use the records
